Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2001;89:461-467
Published online before print August 16, 2001, doi: 10.1161/hh1701.096038
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
89/5/461    most recent
hh1701.096038v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by He, H.
Right arrow Articles by Gottlieb, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by He, H.
Right arrow Articles by Gottlieb, R. A.
Related Collections
Right arrow Biochemistry and metabolism
Right arrow Animal models of human disease
Right arrow Cell signalling/signal transduction
Right arrow Ischemic biology - basic studies
(Circulation Research. 2001;89:461.)
© 2001 American Heart Association, Inc.


Molecular Medicine

Phosphorylation of Mitochondrial Elongation Factor Tu in Ischemic Myocardium

Basis for Chloramphenicol-Mediated Cardioprotection

Huaping He, Min Chen, N. Karoline Scheffler, Bradford W. Gibson, Linda L. Spremulli, Roberta A. Gottlieb

From The Scripps Research Institute (H.H., M.C., R.A.G.), La Jolla, Calif; the Department of Chemistry and Pharmaceutical Chemistry (N.K.S., B.W.G.), University of California San Francisco, San Francisco, Calif; and the Department of Chemistry (L.L.S.), University of North Carolina, Chapel Hill, NC.

Correspondence to Roberta A. Gottlieb, MD, Department of Molecular & Experimental Medicine, MEM220, The Scripps Research Institute, 10550 N Torrey Pines Rd, La Jolla, CA 92037. E-mail robbieg{at}scripps.edu

The objective of this study was to identify the mitochondrial proteins that undergo changes in phosphorylation during global ischemia and reperfusion in the isolated rabbit heart. We also assessed whether the cardioprotective intervention of ischemic preconditioning affected mitochondrial protein phosphorylation. We established a reconstituted system using isolated mitochondria and cytosol from control or ischemic hearts. We found that phosphorylation of a 46-kDa protein on a serine residue was increased in ischemia and that phosphorylation was reduced in control or preconditioned hearts. Using 2D gel electrophoresis and mass spectrometry, we have identified the 46-kDa protein as mitochondrial translational elongation factor Tu (EF-Tumt). These data reveal that ischemia and preconditioning modulate the phosphorylation of EF-Tumt and suggest that the mitochondrial protein synthesis machinery may be regulated by phosphorylation. Phosphorylation of mitochondrial EF-Tu has not been previously described; however, in prokaryotes, EF-Tu phosphorylation inhibits protein translation. We hypothesized that phosphorylation of mitochondrial EF-Tu would inhibit mitochondrial protein translation and attempted to reproduce the effect with inhibition of mitochondrial protein synthesis by chloramphenicol. We found that chloramphenicol pretreatment significantly reduced infarct size, suggesting that mitochondrial protein synthesis is one determinant of myocardial injury during ischemia and reperfusion.


Key Words: ischemia • preconditioning • mitochondria • phosphorylation • chloramphenicol




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. J. Benjamin, Y. Guo, S. Srinivasan, S. Boudina, R. P. Taylor, N. S. Rajasekaran, R. Gottlieb, E. F. Wawrousek, E. D. Abel, and R. Bolli
CRYAB and HSPB2 deficiency alters cardiac metabolism and paradoxically confers protection against myocardial ischemia in aging mice
Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H3201 - H3209.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. Tanaka-Esposito, Q. Chen, S. Moghaddas, and E. J. Lesnefsky
Ischemic preconditioning does not protect via blockade of electron transport
J Appl Physiol, August 1, 2007; 103(2): 623 - 628.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. J. Granville, B. Tashakkor, C. Takeuchi, A. B. Gustafsson, C. Huang, M. R. Sayen, P. Wentworth Jr., M. Yeager, and R. A. Gottlieb
Reduction of ischemia and reperfusion-induced myocardial damage by cytochrome P450 inhibitors
PNAS, February 3, 2004; 101(5): 1321 - 1326.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Takeuchi and T. Ueda
Down-regulation of the Mitochondrial Translation System during Terminal Differentiation of HL-60 cells by 12-O-Tetradecanoyl-1-phorbol-13-acetate: COMPARISON WITH THE CYTOPLASMIC TRANSLATION SYSTEM
J. Biol. Chem., November 14, 2003; 278(46): 45318 - 45324.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. R. Sayen, A. B. Gustafsson, M. A. Sussman, J. D. Molkentin, and R. A. Gottlieb
Calcineurin transgenic mice have mitochondrial dysfunction and elevated superoxide production
Am J Physiol Cell Physiol, February 1, 2003; 284(2): C562 - C570.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Chen, D.-J. Won, S. Krajewski, and R. A. Gottlieb
Calpain and Mitochondria in Ischemia/Reperfusion Injury
J. Biol. Chem., August 2, 2002; 277(32): 29181 - 29186.
[Abstract] [Full Text] [PDF]